SCRIPT content mapped to national antimicrobial stewardship competencies

15th February 2019

A paper published by Professor Molly Courtenay et al developed consensus based national antimicrobial stewardship competencies for UK undergraduate healthcare professional education.

The SCRIPT editorial team have mapped the competencies to our module content to identify any potential gaps in learning. Of the 54 competency descriptors we found only nine, relating to prescribing and therapeutics, where our module content could be enhanced to meet the descriptor.  Additional content has now been authored by the editorial team as either case vignettes, activities or text content to ensure each of the relevant competencies are covered appropriately. This work will be published as a NICE Shared Learning Case Study over the coming weeks.

More News

SCRIPT eLearning Shortlisted for Prestigious HSJ Patient Safety Award

SCRIPT eLearning is delighted to announce that it has been shortlisted in the ‘Patient Safety Education and Training’ category of the HSJ Patient Safety Awards 2026, recognising its ongoing contribution to improving safety in prescribing and medicines management. The...

Birmingham Education for Health Professional Conference 2026

The SCRIPT team was delighted to present a poster at the Birmingham Education for Health Professional Conference 2026, led by our Research Associate Divya Singh. The poster, titled "eLearning in Multidisciplinary Prescribing Education: A Longitudinal Evaluation...

New Modules Under Development

We are committed to developing and adding new modules to ensure the SCRIPT programme continues to reflect current clinical practice and meets our learners’ changing needs. We have several modules at various stages of development, including Drugs of Addiction and...

Updated module – Diabetes: Antihyperglycaemic Medicines

NICE has recently updated its guidance on ‘Type 2 diabetes in adults: management’. In a change to national guidance modified‑release metformin alongside an SGLT2 inhibitor is now recommended as first‑line treatment for adults with type 2 diabetes mellitus....